Oaktree Acquisition III Life Sciences Sponsor Plans Conversion of 4,798,758 Class B Shares to Class A
Oaktree Acquisition III Life Sciences' sponsor plans to convert 4,798,758 Class B ordinary shares into Class A ordinary shares one-for-one. The conversion is planned before an extension takes effect; shareholders will consider the business combination deadline extension on October 16, 2026. Following conversion, sponso